A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury

Journal of Neurotrauma

Volumn 28, Issue 8, 2011, Pages 1525-1543

  Kwon, Brian K ^a   Okon, Elena B ^a   Tsai, Eve ^b   Beattie, Michael S ^c   Bresnahan, Jacqueline C ^c   Magnuson, David K ^d   Reier, Paul J ^e   McTigue, Dana M ^f   Popovich, Phillip G ^f   Blight, Andrew R ^g   Oudega, Martin ^h   Guest, James D ⁱ   Weaver, Lynne C ^j   Fehlings, Michael G ^k   Tetzlaff, Wolfram ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g ACORDA THERAPEUTICS INC   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^j ROBARTS RESEARCH INSTITUTE   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Delphi; grading system; neuroprotection; spinal cord injury

Indexed keywords

ATORVASTATIN; ERYTHROPOIETIN; ESTROGEN; IBUPROFEN; INDOMETACIN; INOSINE; MACROGOL; MAGNESIUM; MINOCYCLINE; NEUROPROTECTIVE AGENT; PIOGLITAZONE; PROGESTERONE; RILUZOLE;

AUTONOMIC DYSREFLEXIA; BEHAVIOR CHANGE; BRAIN CONTUSION; CELL GROWTH; DRUG EFFICACY; HYPOTHERMIA; LOCOMOTION; NEUROPROTECTION; NONHUMAN; REVIEW; SCORING SYSTEM; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; SWIMMING; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; NEUROPROTECTIVE AGENTS; SPINAL CORD INJURIES;

EID: 79960807107     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2010.1296     Document Type: Review

References (36)

1. Arishima, Y., Setoguchi, T., Yamaura, I., Yone, K., and Komiya, S. (2006). Preventive effect of erythropoietin on spinal cord cell apoptosis following acute traumatic injury in rats. Spine 31, 2432-2438. (Pubitemid 44527025)
2. Boran, B.O., Colak, A., and Kutlay, M. (2005) Erythropoietin enhances neurological recovery after experimental spinal cordinjury. Restor. Neurol. Neuroscience 23, 341-345. (Pubitemid 41746167)
3. Brines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Xie, Q.W., Smart, J., Su-Rick, C.J., Pobre, E., Diaz, D., Gomez, D., Hand, C., Coleman, T., and Cerami, A. (2004). Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. USA 101, 14907-14912. (Pubitemid 39410773)
4. Cetin, A., Nas, K., Buyukbayram, H., Ceviz, A., and Olmez, G. (2006). The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats. Eur. Spine J. 15, 1539-1544. (Pubitemid 44583667)
5. Dietrich, W.D. (2003). Confirming an experimental therapy prior to transfer to humans: What is the ideal? J. Rehabil. Res. Dev. 40, 63-69. (Pubitemid 36988681)
6. Downs, S.H., and Black, N. (1998). The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 52, 377-384. (Pubitemid 28438523)
7. Fawcett, J.W., Curt, A., Steeves, J.D., Coleman, W.P., Tuszynski, M.H., Lammertse, D., Bartlett, P.F., Blight, A.R., Dietz, V., Ditunno, J., Dobkin, B.H., Havton, L.A., Ellaway, P.H., Fehlings, M.G., Privat, A., Grossman, R., Guest, J.D., Kleitman, N., Nakamura, M., Gaviria, M., and Short, D. (2007). Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45, 190-205. (Pubitemid 46340848)
8. Fisher, M., Feuerstein, G., Howells, D.W., Hurn, P.D., Kent, T.A., Savitz, S.I., and Lo, E.H. (2009). Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40, 2244-2250.
9. Fisher, M., Hanley, D.F., Howard, G., Jauch, E.C., and Warach, S. (2007). Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. Stroke 38, 245-248. (Pubitemid 46184280)
10. Fumagalli F., Madaschi L., Brenna P., Caffino L., Marfia G., Di Giulio A.M., Racagni G., and Gorio A. (2008). Single exposure to erythropoietin modulates Nerve Growth Factor expression in the spinal cord following traumatic injury: comparison with methylprednisolone. Eur. J. Pharmacol. 578, 19-27. (Pubitemid 350179757)
11. Geisler, F.H., Coleman, W.P., Grieco, G., and Poonian, D. (2001a). Recruitment and early treatment in a multicenter study of acute spinal cord injury. Spine 26, S58-S67. (Pubitemid 34019781)
12. Geisler, F.H., Coleman, W.P., Grieco, G., and Poonian, D. (2001b). The Sygen multicenter acute spinal cord injury study. Spine 26, S87-S98.
13. Gorio, A., Gokmen, N., Erbayraktar, S., Yilmaz, O., Madaschi, L., Cichetti, C., Di Giulio, A.M., Vardar, E., Cerami, A., and Brines, M. (2002). Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl. Acad. Sci. USA 99, 9450-9455. (Pubitemid 34764634)
14. Gorio, A., Madaschi, L., Di, S.B., Carelli, S., Di Giulio, A.M., De, B.S., Coleman, T., Cerami, A., and Brines, M. (2005). Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proc. Natl. Acad. Sci. USA 102, 16379-16384. (Pubitemid 41688922)
15. Grasso, G., Sfacteria, A., Erbayraktar, S., Passalacqua, M., Meli, F., Gokmen, N., Yilmaz, O., La, T.D., Buemi, M., Iacopino, D.G., Coleman, T., Cerami, A., Brines, M., and Tomasello, F. (2006). Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative. J Neurosurg. Spine 4, 310-318. (Pubitemid 47325461)
16. Guìzar-Sahaún G., Rodriguez-Balderas C.A., Franco-Bourland R.E., Martinez-Cruz A., Grijalva I., Ibarra A., and Madrezo I. (2009). Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions. Spinal Cord. 47, 156-160.
17. Hawryluk, G.W., Rowland, J., Kwon, B.K., and Fehlings, M.G. (2008). Protection and repair of the injured spinal cord: A review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg. Focus 25, E2-E13.
18. Huang H., Fan S., Ji X., Zhang Y., Bao F., and Zhang G. (2009). Recombinant human erythropoietin protects against experimental spinal cord trauma injury by regulating expression of the proteins MKP-1 and p-ERK. J. Int. Med. Res. 37, 511-519.
19. Kang C.E., Poon P.C., Tator C.H., and Shoichet M.S. (2009). A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair, Tissue Eng. Part A 15, 595-604.
20. Kaptanoglu, E., Solaroglu, I., Okutan, O., Surucu, H.S., Akbiyik, F., and Beskonakli, E. (2004). Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg. Rev. 27, 113-120. (Pubitemid 38374415)
21. King, V.R., Averill, S.A., Hewazy, D., Priestley, J.V., Torup, L., and Michael-Titus, A.T. (2007). Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur. J. Neurosci. 26, 90-100. (Pubitemid 47035440)
22. Kontogeorgakos V.A., Voulgaris S., Korompilias A.V., Vekris M., Polyzoidis K.S., Bourantas K., and Beris A.E. (2009). The efficacy of erythropoietin on acute spinal cord injury. An experimental study on a rat model. Arch. Orthop. Trauma Surg. 129, 189-194.
23. Kwon, B.K., Roy, J., Lee, J.H., Okon, E.B., Zhang, H., Marx, J.C., and Kindy, M.S. (2009). Magnesium Chloride in a polyetheline glycol formulation as a neuroprotective therapy for acute spinal cord injury: Preclinical refinement and optimization. J. Neurotrauma 26, 1379-1393.
24. Kwon, B.K., Hillyer, J., and Tetzlaff, W. (2010a). Translational research in spinal cord injury: A survey of opinion from the SCI community. J. Neurotrauma 27, 21-33.
25. Kwon, B.K., Okon, E.B., Hillyer, J., Mann C.M. Baptiste D., Weaver L.C., Fehlings M.G., and Tetzlaff, W. (2010b). A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J. Neurotrauma, Epub ahead of print.
26. Lammertse, D., Tuszynski, M.H., Steeves, J.D., Curt, A., Fawcett, J.W., Rask, C., Ditunno, J.F., Fehlings, M.G., Guest, J.D., Ellaway, P.H., Kleitman, N., Blight, A.R., Dobkin, B.H., Grossman, R., Katoh, H., Privat, A., and Kalichman, M. (2007). Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Clinical trial design. Spinal Cord 45, 232-242. (Pubitemid 46340851)
27. Mann, C., Lee, J.H., Liu, J., Stammers, A.M., Sohn, H.M., Tetzlaff, W., and Kwon, B.K. (2008). Delayed treatment of spinal cord injury with erythropoietin or darbepoetin-a lack of neuroprotective efficacy in a contusion model of cord injury. Exp. Neurol. 211, 34-40.
28. O'Collins, V.E., Macleod, M.R., Donnan, G.A., Horky, L.L., van der Worp, B.H., and Howells, D.W. (2006). 1,026 experimental treatments in acute stroke. Ann. Neurol. 59, 467-477. (Pubitemid 43358067)
29. Okutan, O., Solaroglu, I., Beskonakli, E., and Taskin, Y. (2007). Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats. J. Clin. Neurosci. 14, 364-368.
30. Özdemir, M., Cengiz, S.L., Gurbilek, M., Ogun, T.C., and Ustun, M.E. (2005). Effects of Magnesium sulfate on spinal cord tissue lactate and malondialdehyde levels after spinal cord trauma. Magnes. Res. 18, 170-174. (Pubitemid 41453017)
31. Pinzon, A., Marcillo, A., Pabon, D., Bramlett, H.M., Bunge, M.B., and Dietrich, W.D. (2008). A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury. Exp. Neurol. 213, 129-136.
32. Rowland, J.W., Hawryluk, G.W., Kwon, B., and Fehlings, M.G. (2008). Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon. Neurosurg. Focus 25, E2-E13.
33. Tator, C.H. (2006). Review of treatment trials in human spinal cord injury: Issues, difficulties, and recommendations. Neurosurgery 59, 957-982. (Pubitemid 44852056)
34. Vitellaro-Zuccarello, L., Mazzetti, S., Madaschi, L., Bosisio, P., Fontana, E., Gorio, A., and De, B.S. (2008). Chronic erythropoietin- mediated effects on the expression of astrocyte markers in a rat model of contusive spinal cord injury. Neuroscience 151, 452-466.
35. Vitellaro-Zuccarello, L., Mazzetti, S., Madaschi, L., Bosisio, P., Gorio, A., and De, B.S. (2007). Erythropoietin-mediated preservation of the white matter in rat spinal cord injury. Neuroscience 144, 865-877. (Pubitemid 46013988)
36. Yazihan N., Uzuner K., Salman B., Vural M., Koken T., and Arslantas A. (2008). Erythropoietin improves oxidative stress following spinal cord trauma in rats. Injury 39, 1408-1413.